Literature DB >> 22300853

Ovarian cancer: breaking the silence.

.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22300853     DOI： 10.1016/S1470-2045(12)70052-9

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  3 in total

1.  Bevacizumab in ovarian cancer: unanswered questions.

Authors:  Franco Muggia
Journal:  Drugs       Date:  2012-05-07       Impact factor: 9.546

2.  Invasiveness of mouse embryos to human ovarian cancer cells HO8910PM and the role of MMP-9.

Authors:  Xiaoyan Ding; Liaoqiong Fang; Hong Zhang; Hai Qiao; Zhi-Biao Wang
Journal:  Cancer Cell Int       Date:  2012-06-06       Impact factor: 5.722

3.  Identification of Novel Hypoxia Subtypes for Prognosis Based on Machine Learning Algorithms.

Authors:  Jiawei Wang; Tuo Li; Songquan Wei; Gengye Zhao; Cong Ye; Qiuping Ma; Jinchun Ma; Xiaoyan Cheng
Journal:  J Oncol       Date:  2022-09-12       Impact factor: 4.501
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.